Tag archive for ‘Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19’
By editor3 On Tuesday, August 4th, 2020
0 Comments

Converge Biotech Announces the Launch of Vergiflu (Favipiravir 200 mg) in India to Treat Mild to Moderate Covid-19

Hyderabad, August 04, 2020. Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ More...

Live Updates COVID-19 CASES